Stock Scorecard
Stock Summary for Bausch Health Companies Inc (BHC) - $8.19 as of 11/20/2024 7:49:33 PM EST
Total Score
6 out of 30
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for BHC
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for BHC
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for BHC
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for BHC
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for BHC (29 out of 90)
| Stock Price Rating (Max of 10) | 4 |
| Historical Stock Price Rating (Max of 10) | 7 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 2 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 5 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 0 |
Latest News for for BHC
Financial Details for BHC
Company Overview |
|
|---|---|
| Ticker | BHC |
| Company Name | Bausch Health Companies Inc |
| Country | USA |
| Description | Bausch Health Companies Inc. develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology and dermatology. The company is headquartered in Laval, Canada. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 9/30/2024 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 8.19 |
| Price 4 Years Ago | 20.80 |
| Last Day Price Updated | 11/20/2024 7:49:33 PM EST |
| Last Day Volume | 1,131,085 |
| Average Daily Volume | 1,876,308 |
| 52-Week High | 11.46 |
| 52-Week Low | 3.96 |
| Last Price to 52 Week Low | 106.82% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 22.60 |
| Sector PE | 40.32 |
| 5-Year Average PE | 4.08 |
| Free Cash Flow Ratio | 4.20 |
| Industry Free Cash Flow Ratio | 12.03 |
| Sector Free Cash Flow Ratio | 27.97 |
| Current Ratio Most Recent Quarter | 1.19 |
| Total Cash Per Share | 1.95 |
| Book Value Per Share Most Recent Quarter | -3.19 |
| Price to Book Ratio | 18.78 |
| Industry Price to Book Ratio | 5.31 |
| Sector Price to Book Ratio | 20.88 |
| Price to Sales Ratio Twelve Trailing Months | 0.32 |
| Industry Price to Sales Ratio Twelve Trailing Months | 11.82 |
| Sector Price to Sales Ratio Twelve Trailing Months | 7.11 |
| Analyst Buy Ratings | 1 |
| Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
| Total Shares Outstanding | 367,803,000 |
| Market Capitalization | 3,012,306,570 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 11/10/2010 |
| Last Dividend Amount | 0.10 |
| Current Dividend Amount | 1.00 |
| Total Years Dividend Increasing | 0 |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 98.45% |
| 3-Year Dividend Growth Rate Percentage | -7.62% |
| 5-Year Dividend Growth Rate Percentage | 26.49% |
| All-Time Dividend Growth Rate Percentage | 20.68% |
| Dividend Payout Ratio | 0.00% |
Income Statement |
|
| Quarterly Earnings Growth YOY | -61.20% |
| Annual Earnings Growth | -163.11% |
| Reported EPS 12 Trailing Months | -0.48 |
| Reported EPS Past Year | 1.76 |
| Reported EPS Prior Year | 3.51 |
| Net Income Twelve Trailing Months | -178,000,000 |
| Net Income Past Year | -592,000,000 |
| Net Income Prior Year | -225,000,000 |
| Quarterly Revenue Growth YOY | 12.20% |
| 5-Year Revenue Growth | -2.38% |
| Operating Margin Twelve Trailing Months | 0.22 |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 719,000,000 |
| Total Cash Past Year | 947,000,000 |
| Total Cash Prior Year | 564,000,000 |
| Net Cash Position Most Recent Quarter | -20,788,000,000 |
| Net Cash Position Past Year | -21,441,000,000 |
| Long Term Debt Past Year | 22,388,000,000 |
| Long Term Debt Prior Year | 20,766,000,000 |
| Total Debt Most Recent Quarter | 21,507,000,000 |
| Equity to Debt Ratio Past Year | -0.05 |
| Equity to Debt Ratio Most Recent Quarter | -0.06 |
| Total Stockholder Equity Past Year | -1,022,000,000 |
| Total Stockholder Equity Prior Year | -692,000,000 |
| Total Stockholder Equity Most Recent Quarter | -1,174,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 1,066,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 2.90 |
| Free Cash Flow Past Year | 817,000,000 |
| Free Cash Flow Prior Year | -948,000,000 |
Options |
|
| Put/Call Ratio | 0.04 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.22 |
| MACD Signal | 0.33 |
| 20-Day Bollinger Lower Band | 4.75 |
| 20-Day Bollinger Middle Band | 7.34 |
| 20-Day Bollinger Upper Band | 9.94 |
| Beta | 0.74 |
| RSI | 45.28 |
| 50-Day SMA | 7.78 |
| 150-Day SMA | 9.56 |
| 200-Day SMA | 14.42 |
System |
|
| Modified | 11/20/2024 7:20:32 PM EST |